glp 1 patent expiration Ozempic, Wegovy and Rybelsus: The patents behind Novo Nordisk's weight-loss drugs Looming GLP-1 drug patent expirations

Reported side effects Mild headache or fatigue typically transient during initial use Mild gastrointestinal discomfort reported in some oral formulation users Sleep disruption or irritability potential sign of overstimulation Theoretical safety concerns Critical note: Because Dihexa activates the HGF/c-Met pathway which promotes cellular growth and repair there is a theoretical concern that it could potentially stimulate unwanted cell proliferation in individuals with active cancer or high cancer risk

doi:10.1182/blood.V48.1.53.53

We customise our weight loss plans according to your specific needs

Who should not take semaglutide

Managing Low Breast Milk Supply Breast milk supply can sometimes dip due to stress, illness, hormonal changes, or simply with no clear cause